CN114196697B - Method for integrating, digesting and fermenting residual lactose by genome based on arabinose operon - Google Patents
Method for integrating, digesting and fermenting residual lactose by genome based on arabinose operon Download PDFInfo
- Publication number
- CN114196697B CN114196697B CN202111613984.7A CN202111613984A CN114196697B CN 114196697 B CN114196697 B CN 114196697B CN 202111613984 A CN202111613984 A CN 202111613984A CN 114196697 B CN114196697 B CN 114196697B
- Authority
- CN
- China
- Prior art keywords
- gene
- fermentation
- lactose
- plasmid
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title claims abstract description 86
- 239000008101 lactose Substances 0.000 title claims abstract description 78
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 title claims abstract description 46
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 title claims abstract description 46
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 22
- 238000000855 fermentation Methods 0.000 claims abstract description 86
- 230000004151 fermentation Effects 0.000 claims abstract description 83
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 40
- 230000006698 induction Effects 0.000 claims abstract description 12
- 230000029087 digestion Effects 0.000 claims abstract description 4
- 239000013612 plasmid Substances 0.000 claims description 49
- 238000010362 genome editing Methods 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 108091033409 CRISPR Proteins 0.000 claims description 6
- 101150035354 araA gene Proteins 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 101150097746 araB gene Chemical group 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 5
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 4
- 230000010354 integration Effects 0.000 claims description 4
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical group C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 claims description 3
- OIRDTQYFTABQOQ-UHFFFAOYSA-N ara-adenosine Natural products Nc1ncnc2n(cnc12)C1OC(CO)C(O)C1O OIRDTQYFTABQOQ-UHFFFAOYSA-N 0.000 claims description 3
- 230000004060 metabolic process Effects 0.000 claims description 3
- 239000000411 inducer Substances 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 24
- 238000000746 purification Methods 0.000 description 12
- 102000005936 beta-Galactosidase Human genes 0.000 description 7
- 108010005774 beta-Galactosidase Proteins 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- 210000004251 human milk Anatomy 0.000 description 6
- 235000020256 human milk Nutrition 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000003209 gene knockout Methods 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 229960000268 spectinomycin Drugs 0.000 description 3
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- -1 2 ' -FL Chemical class 0.000 description 2
- 241000186146 Brevibacterium Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention belongs to the microbial fermentation technology, and particularly relates to a method for integrating, digesting and fermenting residual lactose by using a genome based on an arabinose operon. To be used forLacZGene and geneLacYGene replacement of the arabinose operon on the genes of the fermentation strainsaraAGene and genearaBGenes to obtain a replacement fermentation strain; then carrying out lactose fermentation by using the replacement fermentation strain; finally, adding arabinose for induction to complete the digestion of the residual lactose after fermentation. Experimental results show that the addition of the inducer arabinose after replacement has a great influence on lactose consumption, and lactose is consumed on a larger level.
Description
Technical Field
The invention belongs to the microbial fermentation technology, and particularly relates to a method for integrating, digesting and fermenting residual lactose by using a genome based on an arabinose operon.
Background
The breast milk oligosaccharide is a common breast milk oligosaccharide, such as 2 ' -FL, 3 ' -SL, 6 ' -SL, LNnt and the like, and the content of the milk and other raw milk is extremely low because the breast milk oligosaccharide is only largely present in the breast milk, and the functions of regulating intestinal flora, facilitating the growth of probiotics, preventing infection of respiratory system and urinary system, regulating immune system, improving organism immunity, promoting the brain development of infants and the like are excellent, so that the addition of the breast milk oligosaccharide into the infant milk powder becomes one of the items of hot hands in the market. BL21 (DE 3) is a commonly used E.coliOne of the bacterial fermentation strains. Lactose is a fermentation substrate commonly used in the fermentation engineering of breast milk oligosaccharide, and in the fermentation experiment of BL21 (DE 3) using lactose as a substrate, the strain per se is often usedLacZThe gene knockout or the activity of the lactose is eliminated, so that the strain can block or eliminate the lactose consumption path originally, thereby reducing the lactose consumption in the unnecessary path and affecting the expression of the target product. In addition, lactose is often excessively added in order to ensure the production of the product during fermentation, so that a large amount of undigested lactose remains in the fermentation broth, and lactose remaining in the fermentation tank greatly influences the subsequent purification work, and lactose decomposing enzyme is added in the current common lactose treatment method, so that the purification cost is increased.
Disclosure of Invention
In the prior art, lactose decomposing enzyme is added in the later period of lactose fermentation to digest residual lactose, so that the purification cost is increased; the invention processes lactose at the end of fermentation, re-excites the consumption of lactose by the strain, reduces the lactose residue in the subsequent fermentation process, and can reduce the purification cost and the required time to a certain extent.
The invention firstly constructs a replacement plasmid which contains beta-galactosidase capable of being editedLacZGene and synthesis permeaseLacYGene editing is performed on lactose-fermented strainsLacZGene and geneLacYGene editing into the arabinose operon region, the replacement plasmid will be the arabinose operonaraAGene and genearaBGene replacement intoLacZGene and geneLacYAnd (3) a gene. During the fermentation processLacZGene and geneLacYGenes are not expressed, but added with arabinose at the end of fermentation, inducedLacZGene and geneLacYThe strain can metabolize lactose remained in the tank body to reduce lactose residue.
The invention adopts the following technical scheme:
a method for digesting residual lactose by genome integration based on arabinose operon comprises the following stepsLacZGene and geneLacYGene replacement of the arabinose operon on the genes of the fermentation strainsaraAGene and genearaBGenes to obtain a replacement fermentation strain; then carrying out lactose fermentation by using the replacement fermentation strain; finally, adding arabinose for induction to complete the digestion of the residual lactose after fermentation. The arabinose promoter takes arabinose as inducer, and when no arabinose exists, the arabinose promoter is leftaraCGene expression, which results inAraCProteins, which distort DNA at the arabinose operon, prevent mRNA transcription, and are behind promotersaraAAnd (3) witharaBGenes are not expressed, but after the addition of arabinose, the arabinose activates the operator region upstream of the promoter, activates the RNA polymerase,araAand (3) witharaBThe gene starts to express. The invention constructs a replacement plasmidLacZGene and geneLacYGene and knockoutaraA、araBGene plasmid ligation to construct a replacement plasmid, i.eLacZGene and geneLacYGene replacement originalaraA、araBGene knockoutaraAGene and genearaBAfter the gene, arabinose cannot be consumed,LacZgene and geneLacYGenes will always be expressed and lactose will always be consumed. During the fermentation processLacZGene and geneLacYGenes are not expressed, but added with arabinose at the end of fermentation, inducedLacZGene and geneLacYThe strain can metabolize lactose remained in the tank body to reduce lactose residue.
In the present invention, CRISP/CAS9 gene editing technology is used toLacZGene and geneLacYGene replacement of the arabinose operon on the genes of the fermentation strainsaraAGene and genearaBAnd (3) a gene. Specifically, the N20 sequence and the sgRNA sequence are inserted on the plasmid, followed by insertionaraABase sequence before genearaBThe base sequence after the gene is inserted between the twoLacZGene and geneLacYGenes to obtain a replacement plasmid; and transferring the replaced plasmid into a fermentation strain by an electrochemical conversion method, culturing overnight, identifying, selecting a strain which is replaced successfully, carrying out plasmid loss, obtaining a replaced fermentation strain, and carrying out subsequent fermentation operation.
In the invention, the time of lactose fermentation is 22-65 hours; the induction time is 10-30 hours; in the induction, the amount of arabinose added is 0.2 to 0.8 mM mM, preferably 0.3 to 0.6mM, based on the final concentration.
In the present invention, the fermentation strain is a conventional lactose fermentation strain and the lactose metabolism gene is knocked out, such as bacteria, fungi, preferably Corynebacterium, brevibacterium, bacillus, saccharomyces, escherichia, especially Corynebacterium glutamicum, brevibacterium, most preferably beta-galactosidase(LacZ) E.coli of (E.coli).
In the prior art, lactose decomposing enzyme is added in the later period of lactose fermentation to digest residual lactose, so that the purification cost is increased; the invention processes lactose at the end of fermentation, re-excites the consumption of lactose by the strain, reduces the lactose residue in the subsequent fermentation process, and can reduce the purification cost and the required time to a certain extent. The invention firstly constructs a replacement plasmid which contains beta-galactosidase capable of being editedLacZGene and synthesis permeaseLacYGene editing is performed on lactose-fermented strainsLacZGene and geneLacYGene editing into the arabinose operon region, the replacement plasmid will be the arabinose operonaraAGene and genearaBGene replacement intoLacZGene and geneLacYAnd (3) a gene. During the fermentation processLacZGene and geneLacYGenes are not expressed, but added with arabinose at the end of fermentation, inducedLacZGene and geneLacYThe strain can metabolize lactose remained in the tank body to reduce lactose residue.
Drawings
FIG. 1 shows the results of monoclonal identification.
Detailed Description
Taking the synthesis of LNnt (lactosyl-N-neotetraose) as an example, the invention first constructs a replacement plasmid, which was identified in the case of pTarget plasmid, using CRISP/CAS9 gene editing technologyaraAOr (b)araBN20 sequence on gene fragment, insertion of N20 and sgRNA on plasmid, followed by insertion of fragment comprisingaraABase sequence of 634bp length before gene and its preparation methodaraBBase sequence 824bp length after gene and inserted between themLacZGene and geneLacYThe fragment size of the gene is 4377bp, thereby constructing a gene containingLacZAnd (3) withLacYThe replacement plasmid of the gene is subjected to the next replacement and fermentation; transferring the plasmid into the strain by electrochemical conversion, culturing overnight, identifying whether replacement is successful, if so, losing the plasmid, and confirming that the plasmid is lost, and then carrying out subsequent fermentation operation.
In the present invention, the gene sequences involved are as follows:
araA gene:
TTAGCGACGAAATCCGTAATACACTTCGTTCCAGCGCAGCGCGTCTTTAAACGCTGGCAGGCGGGTATCGTTATCAATCACCGTGATTTCAATGTCGTGCATCTCGGCGAACTGGCGCATATCGTTGAGGTTCAGCGCATGGCTGAAGACGGTATGGTGCGCGCCACCAGCGAGGATCCACGCTTCGGAAGCAGTTGGCAGATCCGGTTGCGCTTTCCACAGCGCATTCGCCACCGGCAGTTTCGGCAGGGAGTGCGGTGTTTTCACCGTGTCGATACAGTTAACCAGCAGACGGTAACGATCGCCGAGATCAATCAGGCTGGCGACAATCGCTGGACCGGTTTGGGTATTGAAGATCAGTCGGGCAGGATCGTCCTTACCACCAATACCGAGATGCTGAACGTCGAGGATCGGTTTCTCTTCTACGGCAATCGACGGGCAGACTTCCAGCATATGGGAGCCGAGCACCAGGTCATTACCTTTCTCGAAGTGATAGGTGTAGTCCTCCATAAAGGAGGTGCCGCCCTGCAGACCGGTTGACATCACCTTCATGATGCGAAGCAGGGCGGCGGTTTTCCAGTCGCCTTCGCCCGCAAAGCCGTAACCCTGCTGCATCAGACGCTGTACGGCCAGACCTGGAAGCTGTTTCAGACCGTGCAAATCTTCAAAGGTGGTGGTGAACGCGTGGAAGCCACCTTGTTCCAGGAAACGCTTCATCCCCAGCTCAATACGCGCCGCTTCCAGCACGTTCTGTCGTTTTTCGCCGTGGATTTGTGTTGCAGGCGTCATGGTGTAGCAGCTTTCGTACTCATCGACCAGCGCGTTAACATCGCCGTCGCTGATGGAGTTCACCACCTGCACCAGATCGCCAACCGCCCAGGTATTGACGGAGAAACCGAACTTGATCTGTGCGGCAACTTTATCACCATCGGTGACCGCCACTTCACGCATGTTATCGCCAAAACGGCAGACTTTCAGATGACGGGTATCCTGTTTAGAAACCGCCTGACGCATCCAGGAGCCGATACGCTCATGGGCTTGTTTATCCTGCCAGTGACCGGTAACGACGGCATGTTGCTGACGCATACGCGCGCCAATGAAGCCGAACTCGCGACCGCCATGTGCAGTCTGGTTCAGGTTCATAAAGTCCATATCGATACTGTCCCACGGCAGCGCCGCGTTGAACTGGGTGTGGAATTGCAGCAACGGTTTGTTGAGCATGGTCAGGCCGTTGATCCACATTTTGGCCGGGGAGAAGGTGTGCAGCCACACCACCAGACCAGCGCAACGATCGTCGTAATTCGCGTCGCGGCAAATAGCGGTGATTTCATCCGGCGTGGTGCCCAGCGGTTTCAACACCAGTTTGCAGGGCAGTTTCGCTTCCGTATTCAGCGCATTAACAACGTGCTCGGCATGTTGGGTGACCTGACGCAGGGTTTCCGGGCCATACAGATGCTGGCTGCCAATGACAAACCACACTTCATAATTATCAAAAATCGTCAT
araB gene:
TTATAGAGTCGCAACGGCCTGGGCAGCCTGTGCCGGGGCGGAAGTTGGAAGATAGTGTTGTTCGGCGCTCATCGCCCATTGCTGATAGCGGCGATAAAGCTGTTCAAAGCGTTGTGCCTGTTCGCTGCGCGGTTGCAGGGTTTTCTCTACCGCACTGGCCATTTTTTGCTGGGCTGATGGGATGTCTGCGTGCACTTTCGCGGCGACGGCAGCAAAAATCGCCGCACCGAGCGCACAGCACTGGTCAGAGGCAACAATTTGCAGCGGGCGATTCAGCACGTCGCAGCAGGCCTGCATAATGACCTGGTTTTTCCGCGCGATGCCGCCCAGCGCCATCACGTTATTGACGGCGATCCCCTGATCGGTAAAGCACTCCATGATTGCGCGTGCGCCAAAGGCGGTGGCAGCAATCAAACCGCCGAACAGCAGCGGAGCGTCGGTAGCGAGGTTAAGATCGGTAATCACCCCTTTCAGGCGTTGGTTAGCGTTTGGCGAGCGACGACCGTTAAACCAGTCGAGCACCACCGGCAGGTGATCCAGAGACGGATTTTTGGCCCATGCTTCGGTCAGCGCCGGAAGCAGTTGTTTCTGGCTGGCGTTGATTTGCGCTTTCAGTTCCGGATGCTGGGCGGCAAGCTGTTCCAGCGGCCAGCTGAGTACGCGACCGAACCAGGCGTAGATATCACCAAACGCCGATTGGCCTGCTTCCAGACCGATAAATCCAGGCACCACGCTGCCATCAACCTGACCGCAAATACCTTTAACTGCCCGCTCGCCAACGCTCTGTTTGTCGGCAATCAGAATGTCGCAGGTGGAAGTACCGATAACTTTTACCAGTGCGTTAGGCTGTGCGCCTGCGCCAACTGCGCCCATATGGCAGTCAAACGCGCCGCCGGAAATCACCACGCTTTCAGGCAGGCCGAGACGCTGCGCCCATTCCGGGCATAAGGTGCCCACCGGAATATCGGCAGTCCAGGTGTCAGTGAACAGCGGGGAAGGCAAATGGCGATTGAGGATCGGGTCCAGCTCATCAAAGAAACTGGCTGGCGGCAAGCCGCCCCAGCTTTCGTGCCACAGAGATTTATGCCCGGCGCTGCAACGTCCGCGACGAATATCCTGCGGGCGGGTGGTACCGGAAAGCAGAGCTGGCACCCAGTCGCACAGCTCAATCCACGATGCGGCAGATTGCGCCACGGCGCTGTCCTGGCGAGTCACATGCAGGATTTTTGCCCAGAACCATTCGCTGGAATAAATACCGCCAATATAGCGGGAGTAGTCAACATTGCCCGGCGCGTGGCACAAACGGGTAATCTCTTCCGCTTCTTCAACCGCAGTGTGGTCTTTCCACAATACGAACATCGCGTTCGGGTTTTCGGCAAACTCCGGGCGCAGCGCCAGCACGTTACCGTCGGCATCAATCGGTGCGGGCGTCGAGCCGGTACTGTCAACGCCAATCCCGACCACAGCTGCGCGCTGTTCGACGCTAAGCTCTGCAAGCACGGTTTTCAGTGCCGCTTCCATTGACTCAATGTAGTCACGCGGATGATGACGGAACTGGTTATTCGGGGCATCACAAAATTGCCCTTTTTGCCAACGGGGATACCACTCTACGCTGGTGGCGATCTCTTCACCGCTGGCGCAGTCCACCGCCAAAGCTCGCACAGAATCACTGCCAAAATCGAGGCCAATTGCAATCGCCAT
LacZ gene:
TTATTTTTGACACCAGACCAACTGGTAATGGTAGCGACCGGCGCTCAGCTGGAATTCCGCCGATACTGACGGGCTCCAGGAGTCGTCGCCACCAATCCCCATATGGAAACCGTCGATATTCAGCCATGTGCCTTCTTCCGCGTGCAGCAGATGGCGATGGCTGGTTTCCATCAGTTGCTGTTGACTGTAGCGGCTGATGTTGAACTGGAAGTCGCCGCGCCACTGGTGTGGGCCATAATTCAATTCGCGCGTCCCGCAGCGCAGACCGTTTTCGCTCGGGAAGACGTACGGGGTATACATGTCTGACAATGGCAGATCCCAGCGGTCAAAACAGGCGGCAGTAAGGCGGTCGGGATAGTTTTCTTGCGGCCCTAATCCGAGCCAGTTTACCCGCTCTGCTACCTGCGCCAGCTGGCAGTTCAGGCCAATCCGCGCCGGATGCGGTGTATCGCTCGCCACTTCAACATCAACGGTAATCGCCATTTGACCACTACCATCAATCCGGTAGGTTTTCCGGCTGATAAATAAGGTTTTCCCCTGATGCTGCCACGCGTGAGCGGTCGTAATCAGCACCGCATCAGCAAGTGTATCTGCCGTGCACTGCAACAACGCTGCTTCGGCCTGGTAATGGCCCGCCGCCTTCCAGCGTTCGACCCAGGCGTTAGGGTCAATGCGGGTCGCTTCACTTACGCCAATGTCGTTATCCAGCGGTGCACGGGTGAACTGATCGCGCAGCGGCGTCAGCAGTTGTTTTTTATCGCCAATCCACATCTGTGAAAGAAAGCCTGACTGGCGGTTAAATTGCCAACGCTTATTACCCAGCTCGATGCAAAAATCCATTTCGCTGGTGGTCAGATGCGGGATGGCGTGGGACGCGGCGGGGAGTGTCACGCTGAGGTTTTCAGCCAGACGCCACTGCTGCCAGGCGCTGATGTGTCCGGCTTCTGACCATGCGGTCGCGTTCGGTTGCACTACGCGTACTGTGAGCCAGAGTTGCCCGGCGCTCTCCGGCTGCGGTAGTTCAGGCAGTTCAATCAACTGTTTACCTTGTGGAGCGACATCCAGAGGCACTTCACCGCTTGCCAGCGGCTTACCATCCAGCGCCACCATCCAGTGCAGGAGCTCGTTATCGCTATGACGGAACAGGTATTCGCTGGTCACTTCGATGGTTTGCCCGGATAAACGGAACTGGAAAAACTGCTGCTGGTGTTTTGCTTCCGTCAGCGCTGGATGCGGCGTGCGGTCGGCAAAGACCAGACCGTTCATACAGAACTGGCGATCGTTCGGCGTATCGCCAAAATCACCGCCGTAAGCCGACCACGGGTTGCCGTTTTCATCATATTTAATCAGCGACTGATCCACCCAGTCCCAGACGAAGCCGCCCTGTAAACGGGGATACTGACGAAACGCCTGCCAGTATTTAGCGAAACCGCCAAGACTGTTACCCATCGCGTGGGCGTATTCGCAAAGGATCAGCGGGCGCGTCTCTCCAGGTAGCGAAAGCCATTTTTTGATGGACCATTTCGGCACAGCCGGGAAGGGCTGGTCTTCATCCACGCGCGCGTACATCGGGCAAATAATATCGGTGGCCGTGGTGTCGGCTCCGCCGCCTTCATACTGCACCGGGCGGGAAGGATCGACAGATTTGATCCAGCGATACAGCGCGTCGTGATTAGCGCCGTGGCCTGATTCATTCCCCAGCGACCAGATGATCACACTCGGGTGATTACGATCGCGCTGCACCATTCGCGTTACGCGTTCGCTCATCGCCGGTAGCCAGCGCGGATCATCGGTCAGACGATTCATTGGCACCATGCCGTGGGTTTCAATATTGGCTTCATCCACCACATACAGGCCGTAGCGGTCGCACAGCGTGTACCACAGCGGATGGTTCGGATAATGCGAACAGCGCACGGCGTTAAAGTTGTTCTGCTTCATCAGCAGGATATCCTGCACCATCGTCTGCTCATCCATGACCTGACCATGCAGAGGATGATGCTCGTGACGGTTAACGCCTCGAATCAGCAACGGCTTGCCGTTCAGCAGCAGCAGACCATTTTCAATCCGCACCTCGCGGAAACCGACATCGCAGGCTTCTGCTTCAATCAGCGTGCCGTCGGCGGTGTGCAGTTCAACCACCGCACGATAGAGATTCGGGATTTCGGCGCTCCACAGTTTCGGGTTTTCGACGTTCAGACGTAGTGTGACGCGATCGGCATAACCACCACGCTCATCGATAATTTCACCGCCGAAAGGCGCGGTGCCGCTGGCGACCTGCGTTTCACCCTGCCATAAAGAAACTGTTACCCGTAGGTAGTCACGCAACTCGCCGCACATCTGAACTTCAGCCTCCAGTACAGCGCGGCTGAAATCATCATTAAAGCGAGTGGCAACATGGAAATCGCTGATTTGTGTAGTCGGTTTATGCAGCAACGAGACGTCACGGAAAATGCCGCTCATCCGCCACATATCCTGATCTTCCAGATAACTGCCGTCACTCCAGCGCAGCACCATCACCGCGAGGCGGTTTTCTCCGGCGCGTAAAAATGCGCTCAGGTCAAATTCAGACGGCAAACGACTGTCCTGGCCGTAACCGACCCAGCGCCCGTTGCACCACAGATGAAACGCCGAGTTAACGCCATCAAAAATAATTCGCGTCTGGCCTTCCTGTAGCCAGCTTTCATCAACATTAAATGTGAGCGAGTAACAACCCGTCGGATTCTCCGTGGGAACAAACGGCGGATTGACCGTAATGGGATAGGTCACGTTGGTGTAGATGGGCGCATCGTAACCGTGCATCTGCCAGTTTGAGGGGACGACGACAGTATCGGCCTCAGGAAGATCGCACTCCAGCCAGCTTTCCGGCACCGCTTCTGGTGCCGGAAACCAGGCAAAGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAATCCGTAATCATGGTCAT
LacY Gene:
TTAAGCGACTTCATTCACCTGACGACGCAGTAGAGAAAGCGGACCGGGGCCGCTAAGCGTGAACACGGAAATTAAGGTGAAGCCCAGCGCCACCAGACCCAGCACCAGATAAGCGCCCTGGAAACCGATGCTTTCATACATATTGCCCGCCAGTACAGACATAAAAATCATCGCCAGTTGCTTAAAGAAGCAGAAACAGACCAGATAAATCGTCGCTGAAAAACGCACTTCAAACTGGCTGGTAATATATTTAAAGCAGCCCACCAGCAGGAACGGTACTTCAAACATATGCAGCGTTTTCAGAATAACCACTTCCAGCGCTGAGGTGGCGAACGATGAGCCAATAATACGTACAGACATAATAGTGCCAGCCAGCAGCAGGGCGTTTTTCCCACCGATGCGATTAATGATCAGTGGCGCAAAGAACATAATCGAGGCGTTAAGTAATTCGCCCATTGTCGTTACGTAGCCAAATACCCGCGTACCCTGTTCACCGGTAGCAAAGAACGAAGTAAAGAAATTAGCAAACTGTTGGTCAAAAACATCGTAGGTGCAGGAAACGCCAATAACATACAGTGACAAAAACCACAGTTTTGGCTGTCTGAACAGTTCCAGTGCCAGCTTAAGGCTAAATGCCGAATGGTTGGCACCTACCGCATTGGCAACCGTGGCAGAAGAGGGCGCATCCGTTTTGGCGAAAAAGAGTAAAACGGCGAGGATGAGTGCACAGCCAGAGCCCAGCCAGAAAACAAACTGATTATTGATGGTGAACATGATGCCGACAATCGAGGCACACAGCGCCCAGCCAACACAGCCAAACATCCGCGCGCGACCAAATTCGAAATTACTGCGACGGCTGACTTTCTCAATAAATGCCTCTACTGCTGGCGCACCGGCGTTAAAACAAAAGCCTAGATAAATACCACCAACAATCGATCCTACTAAAATGTTGTATTGTAACAGTGGCCCGAAGATAAAAATAAAGAACGGCGCAAACATCACTAACATGCCGGTAATAATCCACAGCAGGTATTTGCGCAGCCCGAGTTTGTCAGAAAGCAGACCAAACAGCGGTTGGAATAATAGCGAGAACAGAGAAATAGCGGCAAAAATAATACCCGTATCACTTTTGCTGATATGGTTGATGTCATGTAGCCAAATCGGGAAAAACGGGAAGTAGGCTCCCATGATAAAAAAGTAAAAGAAAAAGAATAAACCGAACATCCAAAAGTTTGTGTTTTTTAAATAGTACAT
all of the above genes were from E.coli BL21 (DE 3) of the indigenous organism, and the LacZ gene thereof had been knocked out.
Examples
Transformation of strains
The strain used in this example was E.coli BL21 (DE 3), and the LacZ gene thereof had been knocked out and was conventionally modified into a fermentation strain, and it was confirmed that the objective product could be synthesized by fermentation test (this strain will be referred to as E.coli BL21 (DE 3) Y strain hereinafter). The plasmid replicative strains used were E.col DH 5. Alpha. Purchased from Videoside organisms, the pTarget plasmid and the pCas plasmid used were common plasmids sold on the market.
Experimental method
The strain construction of the experiment is to utilize CRISPR/Cas9 gene editing system to carry out beta-galactose nucleoside enzymeLacZGene and permeaseLacYArabinose metabolizing enzyme on gene replacement genomearaBGene and genearaAAnd (3) a gene. Published according to NCBI databaseEColl BL21 (DE 3) information lookuparaB、araA、LacZAndLacYThe gene sequences, primers of Table 1 were designed and all primer synthesis and sequencing work was done by Suzhou Jin Weizhi Co.
The genome integration steps are as follows:
(1) Enzyme metabolizing according to arabinosearaB、araAIs used to determine the position of the substitution and the N20 sequence (N20-1 is TTTTGGATGGAGTGAAACGA and N20-2 is CGCTGGAACGAAGTGTATTA) is determined on an N20 search site (http:// crispor. Tefor. Net/crispor. Py) using the pTargetF plasmid as templatepTS-CP-F/R,343-N20-F/RAfter obtaining the linear plasmid by PCRDH5a competent cells were transformed after ligation by Gibson Assembly Master Mix and plated with spectinomycin resistant plates and incubated overnight in an incubator at 37 ℃; selecting monoclonal shake bacteria and sequencing the next day, sequencing to successfully replace the plasmid of the N20 sequence as positive clone, selecting positive clone shake bacteria for culture and extracting the plasmid to obtain N20-343 plasmid;
(2) Using N20-343 plasmid as template, usingN20-CPF/RObtaining a linearized N20-343 carrier fragment by PCR as a primer;
(3) To be used forEThe coll BL21 genome is used as a template343-HL-F/R、343-HR-F/R、lacZ-CDS-F/RAs primers, upstream and downstream homology arms were obtained by PCRLacZYA sequence;
(4) The linear fragments of the two steps are connected through Gibson Assembly Master Mix, DH5a competent cells are transformed, a spectinomycin resistant plate is coated, the culture is carried out in a culture box at 37 ℃ for overnight, the monoclonal shaking bacteria are selected for identification and sequencing the next day, and the target plasmid is extracted after the sequencing is successful;
(5) Preparing electric transformation competence: when (when)EWhen OD value of the bacterial liquid of the coll BL21 (DE 3) Y reaches 0.8, adding 50 ug/mL kanamycin and 10mmol arabinose to induce for 4 hours, and preparing competence;
(6) Transferring the target plasmid into electrotransformation competence, coating a kanamycin and spectinomycin double-resistance plate on the strain subjected to electrotransformation, culturing overnight at 30 ℃, selecting a monoclonal PCR for identification the next day, and selecting a correct positive monoclonal;
11 single clones are selected for identification, each single clone is identified by using two pairs of primers (343-AS-F: TTATTCAGCAGCGTTTGCTG,343-AS-R1: GATCCTCGACGTTCAGCATC,343-AS-R2: TTTCTCTGTTCTCGCTATTA), if the left side is free of a band and the right side is provided with a band (343-AS-F/R1, the size is 2034 bp), the single clone proves successful replacement, and if the left side is provided with a band (343-AS-F/R2, the size is 1346 bp) and the right side is free of a band, the single clone proves unsuccessful replacement, wherein MARK is shown in the middle of the figure, 100bp, 250bp, 500bp, 750bp, 1000bp and 2000bp are sequentially arranged from bottom to top, and clone numbers 4 and 6 are successful replacement strains and positive clones can be found in the figure;
(7) The positive clone colony is picked to a 4mL LB liquid test tube, IPTG with the final concentration of 1mmol/L and 50 ug/mL kanamycin are added for culturing for 12 hours at 37 ℃, LB solid plates (kanamycin resistance) are streaked, and monoclonal verification is performed to remove the pTargetF plasmid;
(8) The single clone from which pTargetF plasmid was removed was picked up into an antibiotic-free LB liquid test tube, cultured at 42℃for 12 hours, streaked onto an antibiotic-free plate, and a single clone PCR (Cas 9-IS-F: TTATGTTGGTCCATTGGCGC, cas9-IS-R: AGCAAATCATGGTAGGTACC) was picked up to verify whether pCas plasmid was removed, and after successful removal of pTargetF and pCas plasmid by the strain successfully replacing the gene, glycerol bacteria were prepared and designated 343 and stored in a refrigerator at-80 ℃.
The PCR reaction system comprises:
the reaction procedure:
three identical sets of fermentation equipment were used for strain fermentation, labeled as replacement induced set (a, 343+ arabinose), replacement uninduced set (B, 343+ water), and non-replacement induced set (C, 343+), respectively. Inoculating strains into 70ml of culture medium according to the proportion of 1:100, culturing for 8 hours at 37 ℃, using a spectrophotometer to measure the OD value of bacterial liquid, inoculating the bacterial liquid into a 1.5L fermentation tank when the OD value is about 0.5, adding fermentation culture medium which is added before and sterilized together into the tank, not feeding the strains within 8 hours after inoculation, starting feeding after 8 hours, using the same fermentation operation for three strains, wherein the three strains need to use the same fermentation operation, in order to ensure that the three strains have the same physiological state when the arabinose is added later, in the process, keeping the fermentation at 37 ℃, starting to regulate the temperature when the OD value of fermentation reaches 60, then fermenting until the OD value reaches 80 (at least 1 hour needs to be kept at 30 ℃), adding 80g of lactose (lactose adding amount is 200ml,0.4 g/ml), the final concentration is 20g/L, the inducer IPTG (isopropyl-beta-D-thiogalactoside) is 8ml (0.1M), the final concentration is 0.2mM, detecting the lactose content in the liquid phase of the fermentation tank is 37g, and the lactose content of the liquid phase is 35 g when the lactose content reaches 37g/L, detecting the residual content is 35 g, and the residual content is 24 g, and the residual content is detected by the high-quality group of lactose is 35 g, and the residual content is detected by the liquid chromatography group of the lactose content of 35 g; subsequently, the group A fermenter was charged with the final arabinose concentration of 0.5mM for induction (40 ml, concentration of 0.5 g/ml), the group B fermenter was charged with pure water (40 ml), the group C fermenter was charged with the final arabinose concentration of 0.5mM for induction (40 ml, concentration of 0.5 g/ml), the fed-batch fermentation culture was continued, and a sample was taken after 6 hours, a sample was taken after 12 hours, a sample was taken after 24 hours, the residual amount of lactose was detected, and finally the residual lactose content of the group A fermenter was measured to be 0.002g/L, the lactose content of the group B was 3.625g/L, and the lactose content of the group C was 3.447g/L, see Table 2.
The test result shows that the addition of the inducer arabinose after replacement has a great influence on lactose consumption, lactose is consumed on a larger level, the lactose content after water addition is slightly reduced, the reduction amount is far smaller than that of an induction group added with the arabinose, the reduced part is estimated to be the lactose consumed by the target product of the fermentation of the strain per se by analysis on the lactose consumption amount, and the lactose content of the inducer added in the non-replacement (E.coli BL21 (DE 3) Y strain) is slightly reduced, and the reason for the reduction is estimated to be the same as that of the non-induction group.
Similar effects can be obtained by fermenting 2 ' -FL, 3 ' -SL, 6 ' -SL and other products in the same experiment, and the residual lactose is greatly consumed by adding the inducer arabinose after replacement, and the residual lactose is induced for 20 hours, which is within 0.005 g/L.
The existing method for removing residual lactose from fermentation liquor mainly focuses on adding lactose decomposing enzyme during purification, such as directly adding beta-galactosidase into fermentation liquor, and the beta-galactosidase has higher price, and the cost of fermentation is greatly increased when residual lactose is removed every time, and the purification is also greatly increasedCost and time. Construction of plasmids to eliminate also occurs by constructing a plasmid containingLacZPlasmids of genes by means of plasmidsLacZThe beta-galactosidase is synthesized by gene expression, and the beta-galactosidase can decompose lactose, so that the purpose of consuming residual lactose is achieved, but the scheme is often accompanied by the generation of antibiotics and can digest lactose in advance to affect the yield, so that the plasmids can exist in the strain and cannot be lost, antibiotics are often added, the subsequent purification work is also increased, and the purification cost is increased. Therefore, the lactose removing method is simple and quick, does not introduce new substances, and can greatly save the purifying cost. The current method on the market cannot achieve the problem of thoroughly reducing the purification cost, so a method which can not generate new byproducts and remove lactose is urgently needed in the market. The invention mainly aims to solve the problems of increased purification steps and increased cost caused by excessive lactose residue in the fermentation process. The most critical point of the invention is that the original is to beLacZIn the case of gene knockout willLacZGene and geneLacYThe gene is introduced into the strain and inserted into the arabinose operon region, and the genes are only inserted after the operon under the action of an arabinose inducerLacZGene and geneLacYThe gene is expressed and normal fermentation is not affected when arabinose is not added, so that lactose is ensured not to be consumed by the strain in the fermentation process. In the case of lactose as a fermentation substrate, the fermentation substrate willLacZGene knockout postgeneLacYThe region after the gene is inserted into the arabinose operon is continuously fermented for 60 hours on the premise of not influencing the fermentation of the strain, then the arabinose is added for induction, and along with the continuous increase of the fermentation time, lactose is continuously consumed in the process, and the consumption rate is far greater than that of the strain which is not induced or replaced. Therefore, the invention can play a huge role in treating lactose residue in the late fermentation period, and the rate of treating the lactose residue is higher.
Sequence listing
<110> Huangshan same-part Biotech Co., ltd
<120> a method for digesting residual lactose of fermentation by genome integration based on arabinose operon
<160> 23
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1503
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
ttagcgacga aatccgtaat acacttcgtt ccagcgcagc gcgtctttaa acgctggcag 60
gcgggtatcg ttatcaatca ccgtgatttc aatgtcgtgc atctcggcga actggcgcat 120
atcgttgagg ttcagcgcat ggctgaagac ggtatggtgc gcgccaccag cgaggatcca 180
cgcttcggaa gcagttggca gatccggttg cgctttccac agcgcattcg ccaccggcag 240
tttcggcagg gagtgcggtg ttttcaccgt gtcgatacag ttaaccagca gacggtaacg 300
atcgccgaga tcaatcaggc tggcgacaat cgctggaccg gtttgggtat tgaagatcag 360
tcgggcagga tcgtccttac caccaatacc gagatgctga acgtcgagga tcggtttctc 420
ttctacggca atcgacgggc agacttccag catatgggag ccgagcacca ggtcattacc 480
tttctcgaag tgataggtgt agtcctccat aaaggaggtg ccgccctgca gaccggttga 540
catcaccttc atgatgcgaa gcagggcggc ggttttccag tcgccttcgc ccgcaaagcc 600
gtaaccctgc tgcatcagac gctgtacggc cagacctgga agctgtttca gaccgtgcaa 660
atcttcaaag gtggtggtga acgcgtggaa gccaccttgt tccaggaaac gcttcatccc 720
cagctcaata cgcgccgctt ccagcacgtt ctgtcgtttt tcgccgtgga tttgtgttgc 780
aggcgtcatg gtgtagcagc tttcgtactc atcgaccagc gcgttaacat cgccgtcgct 840
gatggagttc accacctgca ccagatcgcc aaccgcccag gtattgacgg agaaaccgaa 900
cttgatctgt gcggcaactt tatcaccatc ggtgaccgcc acttcacgca tgttatcgcc 960
aaaacggcag actttcagat gacgggtatc ctgtttagaa accgcctgac gcatccagga 1020
gccgatacgc tcatgggctt gtttatcctg ccagtgaccg gtaacgacgg catgttgctg 1080
acgcatacgc gcgccaatga agccgaactc gcgaccgcca tgtgcagtct ggttcaggtt 1140
cataaagtcc atatcgatac tgtcccacgg cagcgccgcg ttgaactggg tgtggaattg 1200
cagcaacggt ttgttgagca tggtcaggcc gttgatccac attttggccg gggagaaggt 1260
gtgcagccac accaccagac cagcgcaacg atcgtcgtaa ttcgcgtcgc ggcaaatagc 1320
ggtgatttca tccggcgtgg tgcccagcgg tttcaacacc agtttgcagg gcagtttcgc 1380
ttccgtattc agcgcattaa caacgtgctc ggcatgttgg gtgacctgac gcagggtttc 1440
cgggccatac agatgctggc tgccaatgac aaaccacact tcataattat caaaaatcgt 1500
cat 1503
<210> 2
<211> 1701
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
ttatagagtc gcaacggcct gggcagcctg tgccggggcg gaagttggaa gatagtgttg 60
ttcggcgctc atcgcccatt gctgatagcg gcgataaagc tgttcaaagc gttgtgcctg 120
ttcgctgcgc ggttgcaggg ttttctctac cgcactggcc attttttgct gggctgatgg 180
gatgtctgcg tgcactttcg cggcgacggc agcaaaaatc gccgcaccga gcgcacagca 240
ctggtcagag gcaacaattt gcagcgggcg attcagcacg tcgcagcagg cctgcataat 300
gacctggttt ttccgcgcga tgccgcccag cgccatcacg ttattgacgg cgatcccctg 360
atcggtaaag cactccatga ttgcgcgtgc gccaaaggcg gtggcagcaa tcaaaccgcc 420
gaacagcagc ggagcgtcgg tagcgaggtt aagatcggta atcacccctt tcaggcgttg 480
gttagcgttt ggcgagcgac gaccgttaaa ccagtcgagc accaccggca ggtgatccag 540
agacggattt ttggcccatg cttcggtcag cgccggaagc agttgtttct ggctggcgtt 600
gatttgcgct ttcagttccg gatgctgggc ggcaagctgt tccagcggcc agctgagtac 660
gcgaccgaac caggcgtaga tatcaccaaa cgccgattgg cctgcttcca gaccgataaa 720
tccaggcacc acgctgccat caacctgacc gcaaatacct ttaactgccc gctcgccaac 780
gctctgtttg tcggcaatca gaatgtcgca ggtggaagta ccgataactt ttaccagtgc 840
gttaggctgt gcgcctgcgc caactgcgcc catatggcag tcaaacgcgc cgccggaaat 900
caccacgctt tcaggcaggc cgagacgctg cgcccattcc gggcataagg tgcccaccgg 960
aatatcggca gtccaggtgt cagtgaacag cggggaaggc aaatggcgat tgaggatcgg 1020
gtccagctca tcaaagaaac tggctggcgg caagccgccc cagctttcgt gccacagaga 1080
tttatgcccg gcgctgcaac gtccgcgacg aatatcctgc gggcgggtgg taccggaaag 1140
cagagctggc acccagtcgc acagctcaat ccacgatgcg gcagattgcg ccacggcgct 1200
gtcctggcga gtcacatgca ggatttttgc ccagaaccat tcgctggaat aaataccgcc 1260
aatatagcgg gagtagtcaa cattgcccgg cgcgtggcac aaacgggtaa tctcttccgc 1320
ttcttcaacc gcagtgtggt ctttccacaa tacgaacatc gcgttcgggt tttcggcaaa 1380
ctccgggcgc agcgccagca cgttaccgtc ggcatcaatc ggtgcgggcg tcgagccggt 1440
actgtcaacg ccaatcccga ccacagctgc gcgctgttcg acgctaagct ctgcaagcac 1500
ggttttcagt gccgcttcca ttgactcaat gtagtcacgc ggatgatgac ggaactggtt 1560
attcggggca tcacaaaatt gccctttttg ccaacgggga taccactcta cgctggtggc 1620
gatctcttca ccgctggcgc agtccaccgc caaagctcgc acagaatcac tgccaaaatc 1680
gaggccaatt gcaatcgcca t 1701
<210> 3
<211> 3075
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
ttatttttga caccagacca actggtaatg gtagcgaccg gcgctcagct ggaattccgc 60
cgatactgac gggctccagg agtcgtcgcc accaatcccc atatggaaac cgtcgatatt 120
cagccatgtg ccttcttccg cgtgcagcag atggcgatgg ctggtttcca tcagttgctg 180
ttgactgtag cggctgatgt tgaactggaa gtcgccgcgc cactggtgtg ggccataatt 240
caattcgcgc gtcccgcagc gcagaccgtt ttcgctcggg aagacgtacg gggtatacat 300
gtctgacaat ggcagatccc agcggtcaaa acaggcggca gtaaggcggt cgggatagtt 360
ttcttgcggc cctaatccga gccagtttac ccgctctgct acctgcgcca gctggcagtt 420
caggccaatc cgcgccggat gcggtgtatc gctcgccact tcaacatcaa cggtaatcgc 480
catttgacca ctaccatcaa tccggtaggt tttccggctg ataaataagg ttttcccctg 540
atgctgccac gcgtgagcgg tcgtaatcag caccgcatca gcaagtgtat ctgccgtgca 600
ctgcaacaac gctgcttcgg cctggtaatg gcccgccgcc ttccagcgtt cgacccaggc 660
gttagggtca atgcgggtcg cttcacttac gccaatgtcg ttatccagcg gtgcacgggt 720
gaactgatcg cgcagcggcg tcagcagttg ttttttatcg ccaatccaca tctgtgaaag 780
aaagcctgac tggcggttaa attgccaacg cttattaccc agctcgatgc aaaaatccat 840
ttcgctggtg gtcagatgcg ggatggcgtg ggacgcggcg gggagtgtca cgctgaggtt 900
ttcagccaga cgccactgct gccaggcgct gatgtgtccg gcttctgacc atgcggtcgc 960
gttcggttgc actacgcgta ctgtgagcca gagttgcccg gcgctctccg gctgcggtag 1020
ttcaggcagt tcaatcaact gtttaccttg tggagcgaca tccagaggca cttcaccgct 1080
tgccagcggc ttaccatcca gcgccaccat ccagtgcagg agctcgttat cgctatgacg 1140
gaacaggtat tcgctggtca cttcgatggt ttgcccggat aaacggaact ggaaaaactg 1200
ctgctggtgt tttgcttccg tcagcgctgg atgcggcgtg cggtcggcaa agaccagacc 1260
gttcatacag aactggcgat cgttcggcgt atcgccaaaa tcaccgccgt aagccgacca 1320
cgggttgccg ttttcatcat atttaatcag cgactgatcc acccagtccc agacgaagcc 1380
gccctgtaaa cggggatact gacgaaacgc ctgccagtat ttagcgaaac cgccaagact 1440
gttacccatc gcgtgggcgt attcgcaaag gatcagcggg cgcgtctctc caggtagcga 1500
aagccatttt ttgatggacc atttcggcac agccgggaag ggctggtctt catccacgcg 1560
cgcgtacatc gggcaaataa tatcggtggc cgtggtgtcg gctccgccgc cttcatactg 1620
caccgggcgg gaaggatcga cagatttgat ccagcgatac agcgcgtcgt gattagcgcc 1680
gtggcctgat tcattcccca gcgaccagat gatcacactc gggtgattac gatcgcgctg 1740
caccattcgc gttacgcgtt cgctcatcgc cggtagccag cgcggatcat cggtcagacg 1800
attcattggc accatgccgt gggtttcaat attggcttca tccaccacat acaggccgta 1860
gcggtcgcac agcgtgtacc acagcggatg gttcggataa tgcgaacagc gcacggcgtt 1920
aaagttgttc tgcttcatca gcaggatatc ctgcaccatc gtctgctcat ccatgacctg 1980
accatgcaga ggatgatgct cgtgacggtt aacgcctcga atcagcaacg gcttgccgtt 2040
cagcagcagc agaccatttt caatccgcac ctcgcggaaa ccgacatcgc aggcttctgc 2100
ttcaatcagc gtgccgtcgg cggtgtgcag ttcaaccacc gcacgataga gattcgggat 2160
ttcggcgctc cacagtttcg ggttttcgac gttcagacgt agtgtgacgc gatcggcata 2220
accaccacgc tcatcgataa tttcaccgcc gaaaggcgcg gtgccgctgg cgacctgcgt 2280
ttcaccctgc cataaagaaa ctgttacccg taggtagtca cgcaactcgc cgcacatctg 2340
aacttcagcc tccagtacag cgcggctgaa atcatcatta aagcgagtgg caacatggaa 2400
atcgctgatt tgtgtagtcg gtttatgcag caacgagacg tcacggaaaa tgccgctcat 2460
ccgccacata tcctgatctt ccagataact gccgtcactc cagcgcagca ccatcaccgc 2520
gaggcggttt tctccggcgc gtaaaaatgc gctcaggtca aattcagacg gcaaacgact 2580
gtcctggccg taaccgaccc agcgcccgtt gcaccacaga tgaaacgccg agttaacgcc 2640
atcaaaaata attcgcgtct ggccttcctg tagccagctt tcatcaacat taaatgtgag 2700
cgagtaacaa cccgtcggat tctccgtggg aacaaacggc ggattgaccg taatgggata 2760
ggtcacgttg gtgtagatgg gcgcatcgta accgtgcatc tgccagtttg aggggacgac 2820
gacagtatcg gcctcaggaa gatcgcactc cagccagctt tccggcaccg cttctggtgc 2880
cggaaaccag gcaaagcgcc attcgccatt caggctgcgc aactgttggg aagggcgatc 2940
ggtgcgggcc tcttcgctat tacgccagct ggcgaaaggg ggatgtgctg caaggcgatt 3000
aagttgggta acgccagggt tttcccagtc acgacgttgt aaaacgacgg ccagtgaatc 3060
cgtaatcatg gtcat 3075
<210> 4
<211> 1254
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
ttaagcgact tcattcacct gacgacgcag tagagaaagc ggaccggggc cgctaagcgt 60
gaacacggaa attaaggtga agcccagcgc caccagaccc agcaccagat aagcgccctg 120
gaaaccgatg ctttcataca tattgcccgc cagtacagac ataaaaatca tcgccagttg 180
cttaaagaag cagaaacaga ccagataaat cgtcgctgaa aaacgcactt caaactggct 240
ggtaatatat ttaaagcagc ccaccagcag gaacggtact tcaaacatat gcagcgtttt 300
cagaataacc acttccagcg ctgaggtggc gaacgatgag ccaataatac gtacagacat 360
aatagtgcca gccagcagca gggcgttttt cccaccgatg cgattaatga tcagtggcgc 420
aaagaacata atcgaggcgt taagtaattc gcccattgtc gttacgtagc caaatacccg 480
cgtaccctgt tcaccggtag caaagaacga agtaaagaaa ttagcaaact gttggtcaaa 540
aacatcgtag gtgcaggaaa cgccaataac atacagtgac aaaaaccaca gttttggctg 600
tctgaacagt tccagtgcca gcttaaggct aaatgccgaa tggttggcac ctaccgcatt 660
ggcaaccgtg gcagaagagg gcgcatccgt tttggcgaaa aagagtaaaa cggcgaggat 720
gagtgcacag ccagagccca gccagaaaac aaactgatta ttgatggtga acatgatgcc 780
gacaatcgag gcacacagcg cccagccaac acagccaaac atccgcgcgc gaccaaattc 840
gaaattactg cgacggctga ctttctcaat aaatgcctct actgctggcg caccggcgtt 900
aaaacaaaag cctagataaa taccaccaac aatcgatcct actaaaatgt tgtattgtaa 960
cagtggcccg aagataaaaa taaagaacgg cgcaaacatc actaacatgc cggtaataat 1020
ccacagcagg tatttgcgca gcccgagttt gtcagaaagc agaccaaaca gcggttggaa 1080
taatagcgag aacagagaaa tagcggcaaa aataataccc gtatcacttt tgctgatatg 1140
gttgatgtca tgtagccaaa tcgggaaaaa cgggaagtag gctcccatga taaaaaagta 1200
aaagaaaaag aataaaccga acatccaaaa gtttgtgttt tttaaatagt acat 1254
<210> 5
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
gttttagagc tagaaatagc 20
<210> 6
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
gctagcatta tacctaggac 20
<210> 7
<211> 57
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
ctaggtataa tgctagcttt tggatggagt gaaacgagtt ttagagctag aaatagc 57
<210> 8
<211> 57
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 8
atttctagct ctaaaactaa tacacttcgt tccagcggct agcattatac ctaggac 57
<210> 9
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 9
tctagaacta gtctgcaggg 20
<210> 10
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 10
gaattcaata gatctaagct 20
<210> 11
<211> 37
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 11
ttagatctat tgaattctga taccattcgc gagcctc 37
<210> 12
<211> 66
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 12
tccgtaatca tggtcatttt ttataacctc cttagagctc gaattcccaa aaaaacgggt 60
atggag 66
<210> 13
<211> 37
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 13
aggtgaatga agtcgcttaa gtagtcgcat caggtgt 37
<210> 14
<211> 37
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 14
tgcagactag ttctagagtg agaatggacc aggacgc 37
<210> 15
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 15
atgaccatga ttacggattc 20
<210> 16
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 16
agcgacttca ttcacctgac 20
<210> 17
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 17
ttttggatgg agtgaaacga 20
<210> 18
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 18
cgctggaacg aagtgtatta 20
<210> 19
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 19
ttattcagca gcgtttgctg 20
<210> 20
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 20
gatcctcgac gttcagcatc 20
<210> 21
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 21
tttctctgtt ctcgctatta 20
<210> 22
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 22
ttatgttggt ccattggcgc 20
<210> 23
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 23
agcaaatcat ggtaggtacc 20
Claims (2)
1. Genome integration eliminator based on arabinose operonA method for converting residual lactose from fermentation, characterized byLacZGene and geneLacYGene replacement of the arabinose operon on the genes of the fermentation strainsaraAGene and genearaBGenes, resulting in a replacement fermentation strain BL21 (DE 3); then carrying out lactose fermentation by using the replacement fermentation strain; finally, adding arabinose for induction to complete the digestion of residual lactose after fermentation; the fermentation strain is conventional lactose fermentation strain and knocks out lactose metabolism genes; during induction, the addition amount of the arabinose is 0.2-0.8 mM; the lactose fermentation time is 22-65 hours; the induction time is 10-30 hours; the alternative fermentation strain is prepared by determining the N20 sequence on the araA or araB gene fragment using CRISP/CAS9 gene editing techniques with the pTarget plasmid, inserting the N20 sequence and the sgRNA sequence on the plasmid, followed by insertionaraABase sequence before genearaBThe base sequence after the gene is inserted between the twoLacZGene and geneLacYGenes to obtain a replacement plasmid; transferring the replaced plasmid into a fermentation strain by an electrochemical conversion method, culturing overnight, identifying, and selecting a strain which is replaced successfully to lose the plasmid to obtain a replaced fermentation strain; the gene sequences involved are as follows:
araA gene:
TTAGCGACGAAATCCGTAATACACTTCGTTCCAGCGCAGCGCGTCTTTAAACGCTGGCAGGCGGGTATCGTTATCAATCACCGTGATTTCAATGTCGTGCATCTCGGCGAACTGGCGCATATCGTTGAGGTTCAGCGCATGGCTGAAGACGGTATGGTGCGCGCCACCAGCGAGGATCCACGCTTCGGAAGCAGTTGGCAGATCCGGTTGCGCTTTCCACAGCGCATTCGCCACCGGCAGTTTCGGCAGGGAGTGCGGTGTTTTCACCGTGTCGATACAGTTAACCAGCAGACGGTAACGATCGCCGAGATCAATCAGGCTGGCGACAATCGCTGGACCGGTTTGGGTATTGAAGATCAGTCGGGCAGGATCGTCCTTACCACCAATACCGAGATGCTGAACGTCGAGGATCGGTTTCTCTTCTACGGCAATCGACGGGCAGACTTCCAGCATATGGGAGCCGAGCACCAGGTCATTACCTTTCTCGAAGTGATAGGTGTAGTCCTCCATAAAGGAGGTGCCGCCCTGCAGACCGGTTGACATCACCTTCATGATGCGAAGCAGGGCGGCGGTTTTCCAGTCGCCTTCGCCCGCAAAGCCGTAACCCTGCTGCATCAGACGCTGTACGGCCAGACCTGGAAGCTGTTTCAGACCGTGCAAATCTTCAAAGGTGGTGGTGAACGCGTGGAAGCCACCTTGTTCCAGGAAACGCTTCATCCCCAGCTCAATACGCGCCGCTTCCAGCACGTTCTGTCGTTTTTCGCCGTGGATTTGTGTTGCAGGCGTCATGGTGTAGCAGCTTTCGTACTCATCGACCAGCGCGTTAACATCGCCGTCGCTGATGGAGTTCACCACCTGCACCAGATCGCCAACCGCCCAGGTATTGACGGAGAAACCGAACTTGATCTGTGCGGCAACTTTATCACCATCGGTGACCGCCACTTCACGCATGTTATCGCCAAAACGGCAGACTTTCAGATGACGGGTATCCTGTTTAGAAACCGCCTGACGCATCCAGGAGCCGATACGCTCATGGGCTTGTTTATCCTGCCAGTGACCGGTAACGACGGCATGTTGCTGACGCATACGCGCGCCAATGAAGCCGAACTCGCGACCGCCATGTGCAGTCTGGTTCAGGTTCATAAAGTCCATATCGATACTGTCCCACGGCAGCGCCGCGTTGAACTGGGTGTGGAATTGCAGCAACGGTTTGTTGAGCATGGTCAGGCCGTTGATCCACATTTTGGCCGGGGAGAAGGTGTGCAGCCACACCACCAGACCAGCGCAACGATCGTCGTAATTCGCGTCGCGGCAAATAGCGGTGATTTCATCCGGCGTGGTGCCCAGCGGTTTCAACACCAGTTTGCAGGGCAGTTTCGCTTCCGTATTCAGCGCATTAACAACGTGCTCGGCATGTTGGGTGACCTGACGCAGGGTTTCCGGGCCATACAGATGCTGGCTGCCAATGACAAACCACACTTCATAATTATCAAAAATCGTCAT
araB gene:
TTATAGAGTCGCAACGGCCTGGGCAGCCTGTGCCGGGGCGGAAGTTGGAAGATAGTGTTGTTCGGCGCTCATCGCCCATTGCTGATAGCGGCGATAAAGCTGTTCAAAGCGTTGTGCCTGTTCGCTGCGCGGTTGCAGGGTTTTCTCTACCGCACTGGCCATTTTTTGCTGGGCTGATGGGATGTCTGCGTGCACTTTCGCGGCGACGGCAGCAAAAATCGCCGCACCGAGCGCACAGCACTGGTCAGAGGCAACAATTTGCAGCGGGCGATTCAGCACGTCGCAGCAGGCCTGCATAATGACCTGGTTTTTCCGCGCGATGCCGCCCAGCGCCATCACGTTATTGACGGCGATCCCCTGATCGGTAAAGCACTCCATGATTGCGCGTGCGCCAAAGGCGGTGGCAGCAATCAAACCGCCGAACAGCAGCGGAGCGTCGGTAGCGAGGTTAAGATCGGTAATCACCCCTTTCAGGCGTTGGTTAGCGTTTGGCGAGCGACGACCGTTAAACCAGTCGAGCACCACCGGCAGGTGATCCAGAGACGGATTTTTGGCCCATGCTTCGGTCAGCGCCGGAAGCAGTTGTTTCTGGCTGGCGTTGATTTGCGCTTTCAGTTCCGGATGCTGGGCGGCAAGCTGTTCCAGCGGCCAGCTGAGTACGCGACCGAACCAGGCGTAGATATCACCAAACGCCGATTGGCCTGCTTCCAGACCGATAAATCCAGGCACCACGCTGCCATCAACCTGACCGCAAATACCTTTAACTGCCCGCTCGCCAACGCTCTGTTTGTCGGCAATCAGAATGTCGCAGGTGGAAGTACCGATAACTTTTACCAGTGCGTTAGGCTGTGCGCCTGCGCCAACTGCGCCCATATGGCAGTCAAACGCGCCGCCGGAAATCACCACGCTTTCAGGCAGGCCGAGACGCTGCGCCCATTCCGGGCATAAGGTGCCCACCGGAATATCGGCAGTCCAGGTGTCAGTGAACAGCGGGGAAGGCAAATGGCGATTGAGGATCGGGTCCAGCTCATCAAAGAAACTGGCTGGCGGCAAGCCGCCCCAGCTTTCGTGCCACAGAGATTTATGCCCGGCGCTGCAACGTCCGCGACGAATATCCTGCGGGCGGGTGGTACCGGAAAGCAGAGCTGGCACCCAGTCGCACAGCTCAATCCACGATGCGGCAGATTGCGCCACGGCGCTGTCCTGGCGAGTCACATGCAGGATTTTTGCCCAGAACCATTCGCTGGAATAAATACCGCCAATATAGCGGGAGTAGTCAACATTGCCCGGCGCGTGGCACAAACGGGTAATCTCTTCCGCTTCTTCAACCGCAGTGTGGTCTTTCCACAATACGAACATCGCGTTCGGGTTTTCGGCAAACTCCGGGCGCAGCGCCAGCACGTTACCGTCGGCATCAATCGGTGCGGGCGTCGAGCCGGTACTGTCAACGCCAATCCCGACCACAGCTGCGCGCTGTTCGACGCTAAGCTCTGCAAGCACGGTTTTCAGTGCCGCTTCCATTGACTCAATGTAGTCACGCGGATGATGACGGAACTGGTTATTCGGGGCATCACAAAATTGCCCTTTTTGCCAACGGGGATACCACTCTACGCTGGTGGCGATCTCTTCACCGCTGGCGCAGTCCACCGCCAAAGCTCGCACAGAATCACTGCCAAAATCGAGGCCAATTGCAATCGCCAT
LacZ gene:
TTATTTTTGACACCAGACCAACTGGTAATGGTAGCGACCGGCGCTCAGCTGGAATTCCGCCGATACTGACGGGCTCCAGGAGTCGTCGCCACCAATCCCCATATGGAAACCGTCGATATTCAGCCATGTGCCTTCTTCCGCGTGCAGCAGATGGCGATGGCTGGTTTCCATCAGTTGCTGTTGACTGTAGCGGCTGATGTTGAACTGGAAGTCGCCGCGCCACTGGTGTGGGCCATAATTCAATTCGCGCGTCCCGCAGCGCAGACCGTTTTCGCTCGGGAAGACGTACGGGGTATACATGTCTGACAATGGCAGATCCCAGCGGTCAAAACAGGCGGCAGTAAGGCGGTCGGGATAGTTTTCTTGCGGCCCTAATCCGAGCCAGTTTACCCGCTCTGCTACCTGCGCCAGCTGGCAGTTCAGGCCAATCCGCGCCGGATGCGGTGTATCGCTCGCCACTTCAACATCAACGGTAATCGCCATTTGACCACTACCATCAATCCGGTAGGTTTTCCGGCTGATAAATAAGGTTTTCCCCTGATGCTGCCACGCGTGAGCGGTCGTAATCAGCACCGCATCAGCAAGTGTATCTGCCGTGCACTGCAACAACGCTGCTTCGGCCTGGTAATGGCCCGCCGCCTTCCAGCGTTCGACCCAGGCGTTAGGGTCAATGCGGGTCGCTTCACTTACGCCAATGTCGTTATCCAGCGGTGCACGGGTGAACTGATCGCGCAGCGGCGTCAGCAGTTGTTTTTTATCGCCAATCCACATCTGTGAAAGAAAGCCTGACTGGCGGTTAAATTGCCAACGCTTATTACCCAGCTCGATGCAAAAATCCATTTCGCTGGTGGTCAGATGCGGGATGGCGTGGGACGCGGCGGGGAGTGTCACGCTGAGGTTTTCAGCCAGACGCCACTGCTGCCAGGCGCTGATGTGTCCGGCTTCTGACCATGCGGTCGCGTTCGGTTGCACTACGCGTACTGTGAGCCAGAGTTGCCCGGCGCTCTCCGGCTGCGGTAGTTCAGGCAGTTCAATCAACTGTTTACCTTGTGGAGCGACATCCAGAGGCACTTCACCGCTTGCCAGCGGCTTACCATCCAGCGCCACCATCCAGTGCAGGAGCTCGTTATCGCTATGACGGAACAGGTATTCGCTGGTCACTTCGATGGTTTGCCCGGATAAACGGAACTGGAAAAACTGCTGCTGGTGTTTTGCTTCCGTCAGCGCTGGATGCGGCGTGCGGTCGGCAAAGACCAGACCGTTCATACAGAACTGGCGATCGTTCGGCGTATCGCCAAAATCACCGCCGTAAGCCGACCACGGGTTGCCGTTTTCATCATATTTAATCAGCGACTGATCCACCCAGTCCCAGACGAAGCCGCCCTGTAAACGGGGATACTGACGAAACGCCTGCCAGTATTTAGCGAAACCGCCAAGACTGTTACCCATCGCGTGGGCGTATTCGCAAAGGATCAGCGGGCGCGTCTCTCCAGGTAGCGAAAGCCATTTTTTGATGGACCATTTCGGCACAGCCGGGAAGGGCTGGTCTTCATCCACGCGCGCGTACATCGGGCAAATAATATCGGTGGCCGTGGTGTCGGCTCCGCCGCCTTCATACTGCACCGGGCGGGAAGGATCGACAGATTTGATCCAGCGATACAGCGCGTCGTGATTAGCGCCGTGGCCTGATTCATTCCCCAGCGACCAGATGATCACACTCGGGTGATTACGATCGCGCTGCACCATTCGCGTTACGCGTTCGCTCATCGCCGGTAGCCAGCGCGGATCATCGGTCAGACGATTCATTGGCACCATGCCGTGGGTTTCAATATTGGCTTCATCCACCACATACAGGCCGTAGCGGTCGCACAGCGTGTACCACAGCGGATGGTTCGGATAATGCGAACAGCGCACGGCGTTAAAGTTGTTCTGCTTCATCAGCAGGATATCCTGCACCATCGTCTGCTCATCCATGACCTGACCATGCAGAGGATGATGCTCGTGACGGTTAACGCCTCGAATCAGCAACGGCTTGCCGTTCAGCAGCAGCAGACCATTTTCAATCCGCACCTCGCGGAAACCGACATCGCAGGCTTCTGCTTCAATCAGCGTGCCGTCGGCGGTGTGCAGTTCAACCACCGCACGATAGAGATTCGGGATTTCGGCGCTCCACAGTTTCGGGTTTTCGACGTTCAGACGTAGTGTGACGCGATCGGCATAACCACCACGCTCATCGATAATTTCACCGCCGAAAGGCGCGGTGCCGCTGGCGACCTGCGTTTCACCCTGCCATAAAGAAACTGTTACCCGTAGGTAGTCACGCAACTCGCCGCACATCTGAACTTCAGCCTCCAGTACAGCGCGGCTGAAATCATCATTAAAGCGAGTGGCAACATGGAAATCGCTGATTTGTGTAGTCGGTTTATGCAGCAACGAGACGTCACGGAAAATGCCGCTCATCCGCCACATATCCTGATCTTCCAGATAACTGCCGTCACTCCAGCGCAGCACCATCACCGCGAGGCGGTTTTCTCCGGCGCGTAAAAATGCGCTCAGGTCAAATTCAGACGGCAAACGACTGTCCTGGCCGTAACCGACCCAGCGCCCGTTGCACCACAGATGAAACGCCGAGTTAACGCCATCAAAAATAATTCGCGTCTGGCCTTCCTGTAGCCAGCTTTCATCAACATTAAATGTGAGCGAGTAACAACCCGTCGGATTCTCCGTGGGAACAAACGGCGGATTGACCGTAATGGGATAGGTCACGTTGGTGTAGATGGGCGCATCGTAACCGTGCATCTGCCAGTTTGAGGGGACGACGACAGTATCGGCCTCAGGAAGATCGCACTCCAGCCAGCTTTCCGGCACCGCTTCTGGTGCCGGAAACCAGGCAAAGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAATCCGTAATCATGGTCAT
LacY Gene:
TTAAGCGACTTCATTCACCTGACGACGCAGTAGAGAAAGCGGACCGGGGCCGCTAAGCGTGAACACGGAAATTAAGGTGAAGCCCAGCGCCACCAGACCCAGCACCAGATAAGCGCCCTGGAAACCGATGCTTTCATACATATTGCCCGCCAGTACAGACATAAAAATCATCGCCAGTTGCTTAAAGAAGCAGAAACAGACCAGATAAATCGTCGCTGAAAAACGCACTTCAAACTGGCTGGTAATATATTTAAAGCAGCCCACCAGCAGGAACGGTACTTCAAACATATGCAGCGTTTTCAGAATAACCACTTCCAGCGCTGAGGTGGCGAACGATGAGCCAATAATACGTACAGACATAATAGTGCCAGCCAGCAGCAGGGCGTTTTTCCCACCGATGCGATTAATGATCAGTGGCGCAAAGAACATAATCGAGGCGTTAAGTAATTCGCCCATTGTCGTTACGTAGCCAAATACCCGCGTACCCTGTTCACCGGTAGCAAAGAACGAAGTAAAGAAATTAGCAAACTGTTGGTCAAAAACATCGTAGGTGCAGGAAACGCCAATAACATACAGTGACAAAAACCACAGTTTTGGCTGTCTGAACAGTTCCAGTGCCAGCTTAAGGCTAAATGCCGAATGGTTGGCACCTACCGCATTGGCAACCGTGGCAGAAGAGGGCGCATCCGTTTTGGCGAAAAAGAGTAAAACGGCGAGGATGAGTGCACAGCCAGAGCCCAGCCAGAAAACAAACTGATTATTGATGGTGAACATGATGCCGACAATCGAGGCACACAGCGCCCAGCCAACACAGCCAAACATCCGCGCGCGACCAAATTCGAAATTACTGCGACGGCTGACTTTCTCAATAAATGCCTCTACTGCTGGCGCACCGGCGTTAAAACAAAAGCCTAGATAAATACCACCAACAATCGATCCTACTAAAATGTTGTATTGTAACAGTGGCCCGAAGATAAAAATAAAGAACGGCGCAAACATCACTAACATGCCGGTAATAATCCACAGCAGGTATTTGCGCAGCCCGAGTTTGTCAGAAAGCAGACCAAACAGCGGTTGGAATAATAGCGAGAACAGAGAAATAGCGGCAAAAATAATACCCGTATCACTTTTGCTGATATGGTTGATGTCATGTAGCCAAATCGGGAAAAACGGGAAGTAGGCTCCCATGATAAAAAAGTAAAAGAAAAAGAATAAACCGAACATCCAAAAGTTTGTGTTTTTTAAATAGTACAT;
the N20 sequences were TTTTGGATGGAGTGAAACGA and CGCTGGAACGAAGTGTATTA.
2. An alternative fermentation strain BL21 (DE 3) for integrating residual lactose from digestion fermentation, which is characterized byLacZGene and geneLacYGene replacement of the arabinose operon on the genes of the fermentation strainsaraAGene and genearaBGenes to obtain a replacement fermentation strain; the fermentation strain is conventional lactose fermentation strain and knocks out lactose metabolism genes; the alternative fermentation strain is prepared by determining the N20 sequence on the araA or araB gene fragment using CRISP/CAS9 gene editing techniques with the pTarget plasmid, inserting the N20 sequence and the sgRNA sequence on the plasmid, followed by insertionaraABase sequence before genearaBThe base sequence after the gene is inserted between the twoLacZGene and geneLacYGenes to obtain a replacement plasmid; transferring the replaced plasmid into a fermentation strain by an electrochemical conversion method, culturing overnight, identifying, and selecting a strain which is replaced successfully to lose the plasmid to obtain a replaced fermentation strain; the gene sequences involved are as follows:
araA gene:
TTAGCGACGAAATCCGTAATACACTTCGTTCCAGCGCAGCGCGTCTTTAAACGCTGGCAGGCGGGTATCGTTATCAATCACCGTGATTTCAATGTCGTGCATCTCGGCGAACTGGCGCATATCGTTGAGGTTCAGCGCATGGCTGAAGACGGTATGGTGCGCGCCACCAGCGAGGATCCACGCTTCGGAAGCAGTTGGCAGATCCGGTTGCGCTTTCCACAGCGCATTCGCCACCGGCAGTTTCGGCAGGGAGTGCGGTGTTTTCACCGTGTCGATACAGTTAACCAGCAGACGGTAACGATCGCCGAGATCAATCAGGCTGGCGACAATCGCTGGACCGGTTTGGGTATTGAAGATCAGTCGGGCAGGATCGTCCTTACCACCAATACCGAGATGCTGAACGTCGAGGATCGGTTTCTCTTCTACGGCAATCGACGGGCAGACTTCCAGCATATGGGAGCCGAGCACCAGGTCATTACCTTTCTCGAAGTGATAGGTGTAGTCCTCCATAAAGGAGGTGCCGCCCTGCAGACCGGTTGACATCACCTTCATGATGCGAAGCAGGGCGGCGGTTTTCCAGTCGCCTTCGCCCGCAAAGCCGTAACCCTGCTGCATCAGACGCTGTACGGCCAGACCTGGAAGCTGTTTCAGACCGTGCAAATCTTCAAAGGTGGTGGTGAACGCGTGGAAGCCACCTTGTTCCAGGAAACGCTTCATCCCCAGCTCAATACGCGCCGCTTCCAGCACGTTCTGTCGTTTTTCGCCGTGGATTTGTGTTGCAGGCGTCATGGTGTAGCAGCTTTCGTACTCATCGACCAGCGCGTTAACATCGCCGTCGCTGATGGAGTTCACCACCTGCACCAGATCGCCAACCGCCCAGGTATTGACGGAGAAACCGAACTTGATCTGTGCGGCAACTTTATCACCATCGGTGACCGCCACTTCACGCATGTTATCGCCAAAACGGCAGACTTTCAGATGACGGGTATCCTGTTTAGAAACCGCCTGACGCATCCAGGAGCCGATACGCTCATGGGCTTGTTTATCCTGCCAGTGACCGGTAACGACGGCATGTTGCTGACGCATACGCGCGCCAATGAAGCCGAACTCGCGACCGCCATGTGCAGTCTGGTTCAGGTTCATAAAGTCCATATCGATACTGTCCCACGGCAGCGCCGCGTTGAACTGGGTGTGGAATTGCAGCAACGGTTTGTTGAGCATGGTCAGGCCGTTGATCCACATTTTGGCCGGGGAGAAGGTGTGCAGCCACACCACCAGACCAGCGCAACGATCGTCGTAATTCGCGTCGCGGCAAATAGCGGTGATTTCATCCGGCGTGGTGCCCAGCGGTTTCAACACCAGTTTGCAGGGCAGTTTCGCTTCCGTATTCAGCGCATTAACAACGTGCTCGGCATGTTGGGTGACCTGACGCAGGGTTTCCGGGCCATACAGATGCTGGCTGCCAATGACAAACCACACTTCATAATTATCAAAAATCGTCAT
araB gene:
TTATAGAGTCGCAACGGCCTGGGCAGCCTGTGCCGGGGCGGAAGTTGGAAGATAGTGTTGTTCGGCGCTCATCGCCCATTGCTGATAGCGGCGATAAAGCTGTTCAAAGCGTTGTGCCTGTTCGCTGCGCGGTTGCAGGGTTTTCTCTACCGCACTGGCCATTTTTTGCTGGGCTGATGGGATGTCTGCGTGCACTTTCGCGGCGACGGCAGCAAAAATCGCCGCACCGAGCGCACAGCACTGGTCAGAGGCAACAATTTGCAGCGGGCGATTCAGCACGTCGCAGCAGGCCTGCATAATGACCTGGTTTTTCCGCGCGATGCCGCCCAGCGCCATCACGTTATTGACGGCGATCCCCTGATCGGTAAAGCACTCCATGATTGCGCGTGCGCCAAAGGCGGTGGCAGCAATCAAACCGCCGAACAGCAGCGGAGCGTCGGTAGCGAGGTTAAGATCGGTAATCACCCCTTTCAGGCGTTGGTTAGCGTTTGGCGAGCGACGACCGTTAAACCAGTCGAGCACCACCGGCAGGTGATCCAGAGACGGATTTTTGGCCCATGCTTCGGTCAGCGCCGGAAGCAGTTGTTTCTGGCTGGCGTTGATTTGCGCTTTCAGTTCCGGATGCTGGGCGGCAAGCTGTTCCAGCGGCCAGCTGAGTACGCGACCGAACCAGGCGTAGATATCACCAAACGCCGATTGGCCTGCTTCCAGACCGATAAATCCAGGCACCACGCTGCCATCAACCTGACCGCAAATACCTTTAACTGCCCGCTCGCCAACGCTCTGTTTGTCGGCAATCAGAATGTCGCAGGTGGAAGTACCGATAACTTTTACCAGTGCGTTAGGCTGTGCGCCTGCGCCAACTGCGCCCATATGGCAGTCAAACGCGCCGCCGGAAATCACCACGCTTTCAGGCAGGCCGAGACGCTGCGCCCATTCCGGGCATAAGGTGCCCACCGGAATATCGGCAGTCCAGGTGTCAGTGAACAGCGGGGAAGGCAAATGGCGATTGAGGATCGGGTCCAGCTCATCAAAGAAACTGGCTGGCGGCAAGCCGCCCCAGCTTTCGTGCCACAGAGATTTATGCCCGGCGCTGCAACGTCCGCGACGAATATCCTGCGGGCGGGTGGTACCGGAAAGCAGAGCTGGCACCCAGTCGCACAGCTCAATCCACGATGCGGCAGATTGCGCCACGGCGCTGTCCTGGCGAGTCACATGCAGGATTTTTGCCCAGAACCATTCGCTGGAATAAATACCGCCAATATAGCGGGAGTAGTCAACATTGCCCGGCGCGTGGCACAAACGGGTAATCTCTTCCGCTTCTTCAACCGCAGTGTGGTCTTTCCACAATACGAACATCGCGTTCGGGTTTTCGGCAAACTCCGGGCGCAGCGCCAGCACGTTACCGTCGGCATCAATCGGTGCGGGCGTCGAGCCGGTACTGTCAACGCCAATCCCGACCACAGCTGCGCGCTGTTCGACGCTAAGCTCTGCAAGCACGGTTTTCAGTGCCGCTTCCATTGACTCAATGTAGTCACGCGGATGATGACGGAACTGGTTATTCGGGGCATCACAAAATTGCCCTTTTTGCCAACGGGGATACCACTCTACGCTGGTGGCGATCTCTTCACCGCTGGCGCAGTCCACCGCCAAAGCTCGCACAGAATCACTGCCAAAATCGAGGCCAATTGCAATCGCCAT
LacZ gene:
TTATTTTTGACACCAGACCAACTGGTAATGGTAGCGACCGGCGCTCAGCTGGAATTCCGCCGATACTGACGGGCTCCAGGAGTCGTCGCCACCAATCCCCATATGGAAACCGTCGATATTCAGCCATGTGCCTTCTTCCGCGTGCAGCAGATGGCGATGGCTGGTTTCCATCAGTTGCTGTTGACTGTAGCGGCTGATGTTGAACTGGAAGTCGCCGCGCCACTGGTGTGGGCCATAATTCAATTCGCGCGTCCCGCAGCGCAGACCGTTTTCGCTCGGGAAGACGTACGGGGTATACATGTCTGACAATGGCAGATCCCAGCGGTCAAAACAGGCGGCAGTAAGGCGGTCGGGATAGTTTTCTTGCGGCCCTAATCCGAGCCAGTTTACCCGCTCTGCTACCTGCGCCAGCTGGCAGTTCAGGCCAATCCGCGCCGGATGCGGTGTATCGCTCGCCACTTCAACATCAACGGTAATCGCCATTTGACCACTACCATCAATCCGGTAGGTTTTCCGGCTGATAAATAAGGTTTTCCCCTGATGCTGCCACGCGTGAGCGGTCGTAATCAGCACCGCATCAGCAAGTGTATCTGCCGTGCACTGCAACAACGCTGCTTCGGCCTGGTAATGGCCCGCCGCCTTCCAGCGTTCGACCCAGGCGTTAGGGTCAATGCGGGTCGCTTCACTTACGCCAATGTCGTTATCCAGCGGTGCACGGGTGAACTGATCGCGCAGCGGCGTCAGCAGTTGTTTTTTATCGCCAATCCACATCTGTGAAAGAAAGCCTGACTGGCGGTTAAATTGCCAACGCTTATTACCCAGCTCGATGCAAAAATCCATTTCGCTGGTGGTCAGATGCGGGATGGCGTGGGACGCGGCGGGGAGTGTCACGCTGAGGTTTTCAGCCAGACGCCACTGCTGCCAGGCGCTGATGTGTCCGGCTTCTGACCATGCGGTCGCGTTCGGTTGCACTACGCGTACTGTGAGCCAGAGTTGCCCGGCGCTCTCCGGCTGCGGTAGTTCAGGCAGTTCAATCAACTGTTTACCTTGTGGAGCGACATCCAGAGGCACTTCACCGCTTGCCAGCGGCTTACCATCCAGCGCCACCATCCAGTGCAGGAGCTCGTTATCGCTATGACGGAACAGGTATTCGCTGGTCACTTCGATGGTTTGCCCGGATAAACGGAACTGGAAAAACTGCTGCTGGTGTTTTGCTTCCGTCAGCGCTGGATGCGGCGTGCGGTCGGCAAAGACCAGACCGTTCATACAGAACTGGCGATCGTTCGGCGTATCGCCAAAATCACCGCCGTAAGCCGACCACGGGTTGCCGTTTTCATCATATTTAATCAGCGACTGATCCACCCAGTCCCAGACGAAGCCGCCCTGTAAACGGGGATACTGACGAAACGCCTGCCAGTATTTAGCGAAACCGCCAAGACTGTTACCCATCGCGTGGGCGTATTCGCAAAGGATCAGCGGGCGCGTCTCTCCAGGTAGCGAAAGCCATTTTTTGATGGACCATTTCGGCACAGCCGGGAAGGGCTGGTCTTCATCCACGCGCGCGTACATCGGGCAAATAATATCGGTGGCCGTGGTGTCGGCTCCGCCGCCTTCATACTGCACCGGGCGGGAAGGATCGACAGATTTGATCCAGCGATACAGCGCGTCGTGATTAGCGCCGTGGCCTGATTCATTCCCCAGCGACCAGATGATCACACTCGGGTGATTACGATCGCGCTGCACCATTCGCGTTACGCGTTCGCTCATCGCCGGTAGCCAGCGCGGATCATCGGTCAGACGATTCATTGGCACCATGCCGTGGGTTTCAATATTGGCTTCATCCACCACATACAGGCCGTAGCGGTCGCACAGCGTGTACCACAGCGGATGGTTCGGATAATGCGAACAGCGCACGGCGTTAAAGTTGTTCTGCTTCATCAGCAGGATATCCTGCACCATCGTCTGCTCATCCATGACCTGACCATGCAGAGGATGATGCTCGTGACGGTTAACGCCTCGAATCAGCAACGGCTTGCCGTTCAGCAGCAGCAGACCATTTTCAATCCGCACCTCGCGGAAACCGACATCGCAGGCTTCTGCTTCAATCAGCGTGCCGTCGGCGGTGTGCAGTTCAACCACCGCACGATAGAGATTCGGGATTTCGGCGCTCCACAGTTTCGGGTTTTCGACGTTCAGACGTAGTGTGACGCGATCGGCATAACCACCACGCTCATCGATAATTTCACCGCCGAAAGGCGCGGTGCCGCTGGCGACCTGCGTTTCACCCTGCCATAAAGAAACTGTTACCCGTAGGTAGTCACGCAACTCGCCGCACATCTGAACTTCAGCCTCCAGTACAGCGCGGCTGAAATCATCATTAAAGCGAGTGGCAACATGGAAATCGCTGATTTGTGTAGTCGGTTTATGCAGCAACGAGACGTCACGGAAAATGCCGCTCATCCGCCACATATCCTGATCTTCCAGATAACTGCCGTCACTCCAGCGCAGCACCATCACCGCGAGGCGGTTTTCTCCGGCGCGTAAAAATGCGCTCAGGTCAAATTCAGACGGCAAACGACTGTCCTGGCCGTAACCGACCCAGCGCCCGTTGCACCACAGATGAAACGCCGAGTTAACGCCATCAAAAATAATTCGCGTCTGGCCTTCCTGTAGCCAGCTTTCATCAACATTAAATGTGAGCGAGTAACAACCCGTCGGATTCTCCGTGGGAACAAACGGCGGATTGACCGTAATGGGATAGGTCACGTTGGTGTAGATGGGCGCATCGTAACCGTGCATCTGCCAGTTTGAGGGGACGACGACAGTATCGGCCTCAGGAAGATCGCACTCCAGCCAGCTTTCCGGCACCGCTTCTGGTGCCGGAAACCAGGCAAAGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAATCCGTAATCATGGTCAT
LacY Gene:
TTAAGCGACTTCATTCACCTGACGACGCAGTAGAGAAAGCGGACCGGGGCCGCTAAGCGTGAACACGGAAATTAAGGTGAAGCCCAGCGCCACCAGACCCAGCACCAGATAAGCGCCCTGGAAACCGATGCTTTCATACATATTGCCCGCCAGTACAGACATAAAAATCATCGCCAGTTGCTTAAAGAAGCAGAAACAGACCAGATAAATCGTCGCTGAAAAACGCACTTCAAACTGGCTGGTAATATATTTAAAGCAGCCCACCAGCAGGAACGGTACTTCAAACATATGCAGCGTTTTCAGAATAACCACTTCCAGCGCTGAGGTGGCGAACGATGAGCCAATAATACGTACAGACATAATAGTGCCAGCCAGCAGCAGGGCGTTTTTCCCACCGATGCGATTAATGATCAGTGGCGCAAAGAACATAATCGAGGCGTTAAGTAATTCGCCCATTGTCGTTACGTAGCCAAATACCCGCGTACCCTGTTCACCGGTAGCAAAGAACGAAGTAAAGAAATTAGCAAACTGTTGGTCAAAAACATCGTAGGTGCAGGAAACGCCAATAACATACAGTGACAAAAACCACAGTTTTGGCTGTCTGAACAGTTCCAGTGCCAGCTTAAGGCTAAATGCCGAATGGTTGGCACCTACCGCATTGGCAACCGTGGCAGAAGAGGGCGCATCCGTTTTGGCGAAAAAGAGTAAAACGGCGAGGATGAGTGCACAGCCAGAGCCCAGCCAGAAAACAAACTGATTATTGATGGTGAACATGATGCCGACAATCGAGGCACACAGCGCCCAGCCAACACAGCCAAACATCCGCGCGCGACCAAATTCGAAATTACTGCGACGGCTGACTTTCTCAATAAATGCCTCTACTGCTGGCGCACCGGCGTTAAAACAAAAGCCTAGATAAATACCACCAACAATCGATCCTACTAAAATGTTGTATTGTAACAGTGGCCCGAAGATAAAAATAAAGAACGGCGCAAACATCACTAACATGCCGGTAATAATCCACAGCAGGTATTTGCGCAGCCCGAGTTTGTCAGAAAGCAGACCAAACAGCGGTTGGAATAATAGCGAGAACAGAGAAATAGCGGCAAAAATAATACCCGTATCACTTTTGCTGATATGGTTGATGTCATGTAGCCAAATCGGGAAAAACGGGAAGTAGGCTCCCATGATAAAAAAGTAAAAGAAAAAGAATAAACCGAACATCCAAAAGTTTGTGTTTTTTAAATAGTACAT;
the N20 sequences were TTTTGGATGGAGTGAAACGA and CGCTGGAACGAAGTGTATTA.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111613984.7A CN114196697B (en) | 2021-12-27 | 2021-12-27 | Method for integrating, digesting and fermenting residual lactose by genome based on arabinose operon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111613984.7A CN114196697B (en) | 2021-12-27 | 2021-12-27 | Method for integrating, digesting and fermenting residual lactose by genome based on arabinose operon |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114196697A CN114196697A (en) | 2022-03-18 |
CN114196697B true CN114196697B (en) | 2024-03-12 |
Family
ID=80656808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111613984.7A Active CN114196697B (en) | 2021-12-27 | 2021-12-27 | Method for integrating, digesting and fermenting residual lactose by genome based on arabinose operon |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114196697B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101365785A (en) * | 2002-07-01 | 2009-02-11 | 阿基昂生命科学公司,以生物技术资源部的名义经营 | Process and materials for production of glucosamine and n-acetylglucosamine |
CN105026561A (en) * | 2012-09-28 | 2015-11-04 | 加州大学评议会 | Nutrient conversion by photoautotrophic bacteria for improved diurnal properties |
-
2021
- 2021-12-27 CN CN202111613984.7A patent/CN114196697B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101365785A (en) * | 2002-07-01 | 2009-02-11 | 阿基昂生命科学公司,以生物技术资源部的名义经营 | Process and materials for production of glucosamine and n-acetylglucosamine |
CN105026561A (en) * | 2012-09-28 | 2015-11-04 | 加州大学评议会 | Nutrient conversion by photoautotrophic bacteria for improved diurnal properties |
Non-Patent Citations (3)
Title |
---|
Global Gene Expression Differences Associated with Changes in Glycolytic Flux and Growth Rate in Escherichia coli during the Fermentation of Glucose and Xylose;Ramon Gonzalez等;Biotechnol. Prog.;第第18卷卷;第6-20页 * |
Production of polyhydroxyalkanoates by Herbaspirillum seropedicae grown with different sole carbon sources and on lactose when engineered to express the lacZlacY genes;Ana In´es Catal´an等;Enzyme and Microbial Technology(第第40期期);第1352–1357页 * |
朱玉贤等编著.现代分子生物学.高等教育出版社,1997,第152-153页. * |
Also Published As
Publication number | Publication date |
---|---|
CN114196697A (en) | 2022-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6789436B2 (en) | ATP phosphoribosyltransferase variant and method for producing L-histidine using it | |
CN111433366B (en) | Microorganism having increased glycine production ability and method for producing fermentation composition using the same | |
WO2009096690A2 (en) | Improved promoter, and a production method for l-lysine using the same | |
CN105143439B (en) | Microorganism of corynebacterium genus having improved L-arginine producing ability and method for producing L-arginine using same | |
CN113667682B (en) | YH66-RS11190 gene mutant and application thereof in preparation of L-valine | |
KR20150115009A (en) | L-lysine generation method by fermenting bacteria having modified aconitase gene and/or regulatory element | |
CN112725254B (en) | L-homoserine production strain and construction method and application thereof | |
JPH02502065A (en) | Microorganisms with low acetic acid production ability and methods for producing useful substances using the same | |
KR20190005707A (en) | Microorganism including genetic modification that increase productivity of deoxyviolacein and method for producing deoxyviolacein using the same | |
TWI790378B (en) | Microorganism of the genus corynebacterium producing 5'-xanthosine monophosphate and method for preparing 5'-xanthosine monophosphate using the same | |
CN114196697B (en) | Method for integrating, digesting and fermenting residual lactose by genome based on arabinose operon | |
JPS6062982A (en) | Recombinant dna, bacteria having said recombinant dna and production of l-threonine or l-isoleucine using said bacteria | |
EP3119875B1 (en) | Microorganisms producing l-amino acids and process for producing l-amino acids using the same | |
WO2022124671A1 (en) | Shewanella oneidensis-derived protein expressing microorganism and l-amino acid producing method using same | |
CN112646767B (en) | Strain with enhanced L-glutamic acid productivity and construction method and application thereof | |
CN114107342B (en) | Method for removing lactose in fermentation liquor | |
CN114317583B (en) | Method for constructing recombinant microorganism producing L-valine and nucleic acid molecule used in method | |
CN112725253B (en) | A recombinant strain of modified gene BBD29_14900 and its construction method and application | |
CN112538491B (en) | A recombinant strain producing L-isoleucine based on YH66_08550 gene and its construction method and application | |
CN113652384A (en) | A kind of Lactobacillus paracasei S-NB gene deletion mutant and its construction method and application | |
WO2022071638A1 (en) | Corynebacterium glutamicum variant having enhanced l-citrulline production capacity, and method for producing l-citrulline using same | |
CN117467594B (en) | Genetically engineered bacterium for producing 2' -fucosyllactose and application thereof | |
CN111254158A (en) | A method for eliminating drug-resistant plasmids in Enterobacteriaceae bacteria | |
JPS58175493A (en) | Preparation of guanosine by fermentation process | |
CN114540262B (en) | Method for constructing recombinant microorganism producing L-valine and nucleic acid molecules and biological materials used therein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |